Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review
Patients with chronic kidney disease (CKD) often experience mild cognitive impairment and other neurocognitive disorders. Studies have shown that erythropoietin (EPO) and its receptor have neuroprotective effects in cell and animal models of nervous system disorders. Recombinant human EPO (rHuEPO),...
Saved in:
Main Authors: | Michelangela Barbieri (Author), Paolo Chiodini (Author), Piergiacomo Di Gennaro (Author), Gaye Hafez (Author), Sophie Liabeuf (Author), Jolanta Malyszko (Author), Laila-Yasmin Mani (Author), Francesco Mattace-Raso (Author), Marion Pepin (Author), Norberto Perico (Author), Mariadelina Simeoni (Author), Carmine Zoccali (Author), Giovanni Tortorella (Author), Annalisa Capuano (Author), Giuseppe Remuzzi (Author), Giovambattista Capasso (Author), Giuseppe Paolisso (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute kidney injury in low-income and middle-income countries: no longer a death sentence
by: Norberto Perico, et al.
Published: (2016) -
Chronic kidney disease in sub-Saharan Africa: a public health priority
by: Norberto Perico, et al.
Published: (2014) -
Chronic Kidney Disease (CKD) as a Systemic Disease: Whole Body Autoregulation and Inter-Organ Cross-Talk
by: Carmine Zoccali, et al.
Published: (2014) -
INNATE IMMUNITY AND CKD PROGRESSION
by: Mallamaci F, et al.
Published: (2012) -
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
by: Kohji Ohki, et al.
Published: (2020)